` TEZOL.E (Europap Tezol Kagit Sanayi Ve Ticaret AS) vs HEN3 (Henkel AG & Co KGaA) Comparison - Alpha Spread

TEZOL.E
vs
HEN3

Over the past 12 months, TEZOL.E has outperformed HEN3, delivering a return of +18% compared to the HEN3's +1% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
TEZOL.E
HEN3
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

TEZOL.E Intrinsic Value
9.7 TRY
Overvaluation 48%
Intrinsic Value
Price ₺18.8
HEN3 Intrinsic Value
92.47 EUR
Undervaluation 29%
Intrinsic Value
Price €66.04
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
18.8 TRY
Henkel AG & Co KGaA
XETRA:HEN3
66.04 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
TEZOL.E, HEN3

TEZOL.E
HEN3
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Europap Tezol Kagit Sanayi Ve Ticaret AS
Revenue
Henkel AG & Co KGaA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
TEZOL.E, HEN3

TEZOL.E
HEN3
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
Henkel AG & Co KGaA
XETRA:HEN3
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

TEZOL.E
12.8%
HEN3
50.9%

Operating Margin

TEZOL.E
4.5%
HEN3
14.4%

Net Margin

TEZOL.E
3.3%
HEN3
9.9%

FCF Margin

TEZOL.E
12.4%
HEN3
9.8%

ROE

TEZOL.E
3.5%
HEN3
10.3%

ROA

TEZOL.E
2.7%
HEN3
6.3%

ROIC

TEZOL.E
2.4%
HEN3
8.7%

ROCE

TEZOL.E
4.4%
HEN3
12.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
TEZOL.E, HEN3

Loading
TEZOL.E
HEN3
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TEZOL.E, HEN3

Loading
TEZOL.E
HEN3
Difference
www.alphaspread.com

Performance By Year
TEZOL.E, HEN3

Loading
TEZOL.E
HEN3
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare TEZOL.E to other stocks
PG
Procter & Gamble Co
Cheaper
vs TEZOL.E
CL
Colgate-Palmolive Co
Cheaper
vs TEZOL.E
RKT
Reckitt Benckiser Group PLC
Cheaper
vs TEZOL.E
KMB
Kimberly-Clark Corp
Cheaper
vs TEZOL.E
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett